Skip to main content
. 2016 Feb 29;113(11):3018–3023. doi: 10.1073/pnas.1521827113

Table S2.

Histone deacetylase inhibitors included in the compound library

HDAC inhibitor Hit? HDAC target
Panobinostat (LBH-589) Yes HDAC1, HDAC2, HDAC3, HDAC6
AR-42 (HDAC-42) Yes Pan inhibitor
Trichostatin A (TSA) Yes Pan inhibitor
Vorinostat (SAHA) Yes HDAC1, HDAC2, HDAC3, HDAC6
Entinostat (MS-275) Yes HDAC1, HDAC2, HDAC3, HDAC9
Abexinostat (PCI-24781) Yes HDAC1, HDAC2, HDAC3, HDAC6, HDAC10
Dacinostat (NVP-LAQ824) Yes HDAC1, HDAC3, HDAC4, HDAC6
Quisinostat (JNJ-26481585) Yes Pan inhibitor
CUDC-101 Yes Pan-HDAC, EGFR, HER2
Pracinostat (SB939) Yes Pan inhibitor
Givinostat (ITF2357) Yes HDAC1, HDAC2, HDAC3, HDAC4, HDAC6, HDAC7
CUDC-907 Yes Pan-HDAC and PI3K
M344 Yes Pan inhibitor
Romidepsin (FK228) Yes HDAC1, HDAC2, HDAC3, HDAC8
Tubastatin HCl No (negative control) HDAC6
Belinostat (PXD101) No HDAC1, HDAC2, HDAC3, HDAC6
Mocetinostat (MGCD0103) No HDAC1, HDAC2
Droxinostat No HDAC3, HDAC6, HDAC8
MC1568 No HDAC4, HDAC5, HDAC7, HDAC9
PCI-34051 No HDAC8
Tacedinaline (CI-994) No HDAC1, HDAC2, HDAC3

Histone deacetylase inhibitors, specification of screening status, and recognized HDAC target specificity are shown.